Unaware of internal dispute in Cong: Karnataka Dy CM

Mangaluru, Jul 4: The General Secretary of the Dakshina Kannada district unit of Bharatiya Janata Party’s youth wing (Yuva Morcha) has been tested positive for COVID-19 on Saturday.

In a tweet, Sooraj Jain Marnad, has confirmed that he was tested positive for COVID-19.

"I have been tested COVID19 positive. With all your blessings, I’m recovering & will be under treatment for a few days," the tweet said.

The district has witnessed a huge spike in COVID-19 cases in the past few days. The total tally of the district has already crossed 1000 mark. 22 COVID-19 positive patients in the district have died so far.

I have been tested COVID19 positive.
With all your blessings, I'm recovering & will be under treatment for few days.

Requesting everyone to please maintain social distancing, wear mask while going out and wash hands frequently.
Please take care of yourselves & your near one's.

— Sooraj Jain Marnad (@JainMarnad) July 4, 2020

Bengaluru, Apr 28: There are a total of 523 COVID-19 positive cases have been confirmed in the state, Department of Health and Family Welfare of Karnataka informed on Tuesday.
It informed that there are 295 active COVID-19 cases in Karnataka presently, while 207 patients have been discharged, 20 deaths have been reported.

According to a district-wise breakup, a maximum of 131 cases were reported from Bengaluru urban, followed by Mysuru with 87 cases and Belagavi with 52 cases.

India's total number of coronavirus positive cases rises to 29,974 (including 22010 active cases, 7027 cured/discharged/migrated and 937 deaths), Ministry of Health and Family Welfare said on Tuesday.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.